Named Patient Program

Hayatalhikmah offers Post-Approval Named Patient Programs (NPPs) that ensure patients continue receiving life-saving treatments even after clinical trials are completed but before full commercial availability. We manage the regulatory and logistical complexities to provide access to medications for patients in need.

Regulatory Expertise

We manage the regulatory approvals required to ensure that post-approval drugs can be made available to patients before commercial release.

Patient-Centered Medication Access

Our NPPs are designed to prioritize patients who need access to medications during the critical period before they are fully commercially available.

Seamless Global Distribution

We handle the global logistics required to distribute post-approval medications to patients worldwide, ensuring safe and timely delivery

Commitment You Can Count On

No false promises. No shortcuts. We believe in honesty and genuine partnerships. It’s an authentic service from the beginning to the end of the import process.